FDA seeks dismissal of Mylan's lawsuit regarding generic Lipitor

04/7/2011 | Wall Street Journal, The

The FDA petitioned a federal judge to dismiss a lawsuit from Mylan that seeks an injunction forcing the agency to deny a six-month exclusivity period for Ranbaxy Laboratories' generic version of Lipitor, Pfizer's cholesterol-lowering drug. The agency said Mylan's legal action is premature because the agency has not approved any generic Lipitor.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ